Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression

Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer

(2017) RuiQi Chen et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

(2017) et al.   JAMA Oncology

Intracellular Progesterone Receptor Mediates the Increase in Glioblastoma Growth Induced by Progesterone in the Rat Brain

(2016) Liliana Germán-Castelán et al.   ARCHIVES OF MEDICAL RESEARCH

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

(2016) Jonathan I. Epstein et al.   EUROPEAN UROLOGY

Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis

(2015) Subhamoy Dasgupta et al.   JOURNAL OF CLINICAL INVESTIGATION

Progesterone receptor modulates ERα action in breast cancer

(2015) Hisham Mohammed et al.   NATURE

Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation

(2015) Yue Yu et al.   PROSTATE

The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival

(2015) Kaja Skjefstad et al.   STEROIDS

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure

(2015) Thea Grindstad et al.   PLoS One

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

(2014) Tomasz M. Beer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

(2014) A R Daniel et al.   ONCOGENE

Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility

(2014) Yue Yu et al.   PLoS One

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time

(2014) Sigve Andersen et al.   BMC Urology

Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

(2014) Masis Isikbay et al.   Hormones & Cancer

Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade

(2013) Vivek K. Arora et al.   CELL

Expression and Function of the Progesterone Receptor in Human Prostate Stroma Provide Novel Insights to Cell Proliferation Control

(2013) Yue Yu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

(2012) Charles J. Ryan et al.   NEW ENGLAND JOURNAL OF MEDICINE

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones

(2008) Mary-Ellen Taplin et al.   BJU INTERNATIONAL